Study With Improved Solubility Pazopanib
NCT02810756
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Pharmacokinetics of Pazopanib
Interventions
DRUG:
New Pazopanib formulation
Sponsor
The Netherlands Cancer Institute